Obtaining research biopsies during pediatric colonoscopy: Safety and adverse events

Table 1 Participant demographics

	Research group(n = 38)	Control group(n = 84)	P value1
Sex
Male, n (%)	20 (52.6)	48 (57.1)	0.64
Female, n (%)	18 (47.4)	36 (42.9)
Age in years, n (%)
0-5	1 (2.6)	16 (19.0)	0.05
6-12	10 (26.3)	19 (22.6)
13-21	27 (71.1)	49 (58.3)
Race
White, n (%)	5 (13.2)	26 (31)	0.04
Non-white, n (%)	33 (86.8)	58 (69)
Diagnosis
IBD2, n (%)	17 (44.7)	21 (25)	0.03
Normal histology, n (%)	21 (55.3)	63 (75)
IBD diagnosis
CD3, n (%)	11 (28.9)	10 (11.9)	0.23
UC4, n (%)	5 (13.2)	11 (13)
IC5, n (%)	1 (2.6)	0
History of IBD
Yes	8	12	0.54
No	9	9

¹All P values calculated to significance level of 0.05,

²Inflammatory Bowel Disease,

³Crohn’s disease,

⁴Ulcerative colitis,

⁵Indeterminate colitis.